Back to Search Start Over

Mechanisms and Active Compounds Polysaccharides and Bibenzyls of Medicinal Dendrobiums for Diabetes Management.

Authors :
Li M
Trapika IGSC
Tang SYS
Cho JL
Qi Y
Li CG
Li Y
Yao M
Yang D
Liu B
Li R
Yang P
Ma G
Ren P
Huang X
Xie D
Chen S
Li M
Yang L
Leng P
Huang Y
Li GQ
Source :
Frontiers in nutrition [Front Nutr] 2022 Jan 28; Vol. 8, pp. 811870. Date of Electronic Publication: 2022 Jan 28 (Print Publication: 2021).
Publication Year :
2022

Abstract

Background: Medicinal dendrobiums are used popularly in traditional Chinese medicine for the treatment of diabetes, while their active compounds and mechanism remain unclear. This review aimed to evaluate the mechanism and active compounds of medicinal dendrobiums in diabetes management through a systematic approach.<br />Methods: A systematic approach was conducted to search for the mechanism and active phytochemicals in Dendrobium responsible for anti-diabetic actions using databases PubMed, Embase, and SciFinder.<br />Results: Current literature indicates polysaccharides, bibenzyls, phenanthrene, and alkaloids are commonly isolated in Dendrobium genusin which polysaccharides and bibenzyls are most aboundant. Many animal studies have shown that polysaccharides from the species of Dendrobium provide with antidiabetic effects by lowering glucose level and reversing chronic inflammation of T2DM taken orally at 200 mg/kg. Dendrobium polysaccharides protect pancreatic β-cell dysfunction and insulin resistance in liver. Dendrobium polysaccharides up-regulate the abundance of short-chain fatty acid to stimulate GLP-1 secretion through gut microbiota. Bibenzyls also have great potency to inhibit the progression of the chronic inflammation in cellular studies.<br />Conclusion: Polysaccharides and bibenzyls are the major active compounds in medicinal dendrobiums for diabetic management through the mechanisms of lowering glucose level and reversing chronic inflammation of T2DM by modulating pancreatic β-cell dysfunction and insulin resistance in liver as a result from gut microbita regulation.<br />Competing Interests: DX, SC, and YH was employed by the company Chengdu Tepu Biotech Co. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The authors declare that this study received funding from Sichuan Science and Technology Program. The funder was not involved in the study design, collection, analysis, interpretation of data, the writing of this article or the decision to submit it for publication.<br /> (Copyright © 2022 Li, Trapika, Tang, Cho, Qi, Li, Li, Yao, Yang, Liu, Li, Yang, Ma, Ren, Huang, Xie, Chen, Li, Yang, Leng, Huang and Li.)

Details

Language :
English
ISSN :
2296-861X
Volume :
8
Database :
MEDLINE
Journal :
Frontiers in nutrition
Publication Type :
Academic Journal
Accession number :
35155528
Full Text :
https://doi.org/10.3389/fnut.2021.811870